Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

INTI

Inhibitor Therapeutics (QB) (INTI)

Inhibitor Therapeutics Inc (QB)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:INTI

1

Data	Hora	Fonte	Título	Código	Companhia
16/05/2024	14:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
13/05/2024	10:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
14/12/2023	08:02	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
29/08/2023	15:42	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
31/05/2023	17:31	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
23/05/2023	13:50	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
22/05/2023	16:45	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
18/05/2023	07:02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
17/05/2023	20:47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
15/05/2023	10:04	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
30/03/2022	10:02	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
10/02/2020	18:21	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)